Staging of non-small cell lung cancer (NSCLC): A review

被引：173
作者：
Tsim, S. [2 ]
O'Dowd, C. A. [3 ]
Milroy, R. [4 ]
Davidson, S. [1 ]
机构：
[1] So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland
[2] Crosshouse Hosp, Kilmarnock KA2 0BE, Scotland
[3] Gartnavel Royal Hosp, SpR Resp Med, Glasgow G12 0YN, Lanark, Scotland
[4] Stobhill Hosp, Glasgow G21 3UW, Lanark, Scotland
来源：
RESPIRATORY MEDICINE | 2010年 / 104卷 / 12期
关键词：
Lung cancer; NSCLC; TNM; Staging; PET; CT; FORTHCOMING 7TH EDITION; POSITRON-EMISSION-TOMOGRAPHY; C-REACTIVE PROTEIN; TNM CLASSIFICATION; INTERNATIONAL ASSOCIATION; PROJECT; PROPOSALS; REVISION; PERFORMANCE; DIAGNOSIS;
D O I：
10.1016/j.rmed.2010.08.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Lung cancer remains the most common cause of cancer related mortality in Scotland, accounting for 28 9% of all cancer deaths in 2007 (1) Current guidelines recommend assessment of patient fitness and operability by a multi disciplinary team when selecting management options (2-6) Two of the most important prognostic markers are the stage of disease and ECOG performance status The most commonly used cancer staging system is the tumour, node, metastasis (TNM) staging system, which is maintained by the American Joint Committee on Cancer (AJCC) and the International Union Against Cancer (UICC) In 1998, the International Association for the Study of Lung Cancer (IASLC) established The Lung Cancer Staging Project, collecting data on over 100,000 patients diagnosed with lung cancer between 1990-2000 worldwide, in order to revise the 6th edition TNM staging system for non small cell lung cancer (NSCLC) (7) The 7th edition was published in late 2009 This review of staging in NSCLC, includes a summary of the different staging techniques currently available and the 7th edition TNM staging system for NSCLC (8) (C) 2010 Elsevier Ltd All rights reserved
引用
收藏
页码：1767 / 1774
页数：8
相关论文
共 48 条
[1]  
*AM THOR SOC EUR R, 1997, AM J RESP CRIT CARE, V156, P321
[2]  
[Anonymous], 1998, Thorax, V53 Suppl 1, pS1
[3]  
[Anonymous], AM JOINT COMMITTEE C
[4]  
[Anonymous], 2010, AJCC CANC STAGING MA, V7th
[5]  
[Anonymous], 1989, Lung Cancer, DOI DOI 10.1016/0169-5002(89)90156-6
[6]   Non-small cell lung cancer: Dual-modality PET/CT in preoperative staging [J].
Antoch, G ;
Stattaus, J ;
Nemat, AT ;
Marnitz, S ;
Beyer, T ;
Kuehl, H ;
Bockisch, A ;
Debatin, JF ;
Freudenberg, LS .
RADIOLOGY, 2003, 229 (02) :526-533
[7]   STAGING NONSMALL CELL LUNG-CANCER [J].
ARMSTRONG, P ;
VINCENT, JM .
CLINICAL RADIOLOGY, 1993, 48 (01) :1-10
[8]   The International Association for the Study of Lung Cancer Staging Project Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer [J].
Chansky, Kari ;
Sculier, Jean-Paul ;
Crowley, John J. ;
Giroux, Dori ;
Van Meerbeeck, Jan ;
Goldstraw, Peter .
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (07) :792-801
[9]   Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer [J].
Cheran, SK ;
Herndon, JE ;
Patz, EF .
LUNG CANCER, 2004, 44 (03) :317-325
[10]   Physiologic evaluation of the patient with lung cancer being considered for resectional surgery - ACCP evidenced-based clinical practice guidelines (2nd edition) [J].
Colice, Gene L. ;
Shafazand, Shirin ;
Griffin, John P. ;
Keenan, Robert ;
Bolliger, Chris T. .
CHEST, 2007, 132 (03) :161S-177S
12345